Hudson Bay Capital Management
PDSB icon

Hudson Bay Capital Management’s PDS Biotechnology PDSB Stock Holding History

Hudson Bay Capital Management’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-75,342
Closed -$55K – 542
2020
Q1 		$55K Buy
+75,342
New +$131K ﹤0.01% 444

Other funds holding PDSB

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
AFM
Andesa Financial Management Allentown, Pennsylvania $195M AUM 2.34% 1-Year Est. Return

Hudson Bay Capital Management's PDSB Position: Q2 2020 in Review

Hudson Bay Capital Management sold out of PDS Biotechnology (PDSB) in Q2 2020, closing a stake of 75,342 shares — an estimated $55K sold.

Hudson Bay Capital Management first reported a position in PDSB in Q1 2020 and held it in 1 quarter. The position peaked at $55K in Q1 2020. 25 funds tracked by Wall St. Rank hold PDSB as of Q2 2020.

  • Hudson Bay Capital Management reported no remaining PDS Biotechnology position as of Q2 2020 after selling out during the quarter.
  • Hudson Bay Capital Management sold 75,342 PDS Biotechnology shares in Q2 2020, an estimated $55K.
  • Hudson Bay Capital Management first reported a position in PDS Biotechnology in Q1 2020 and held it in 1 quarter.
  • Hudson Bay Capital Management's PDS Biotechnology position peaked at $55K in Q1 2020.
  • 25 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2020.

Based on Hudson Bay Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.